The White House is planning cuts in federal health agencies, risking jobs and impacting drug approvals and medical research. Eli Lilly is advancing its GLP-1 weight loss drug, orforglipron, into…
### BRAIN Biotech's Latest Performance Shakes Investor Confidence BRAIN Biotech AG (ETR:BNN) unveiled its annual report, revealing disappointing financial results. The company reported revenues of **€55 million**, falling short of…
Important changes are coming to U.S. export laws! On Wednesday, the U.S. Department of Commerce revealed plans to impose new restrictions on the export of specific biotechnology equipment, driven by…
A Strong Buy Signal for Investors Recently, Puma Biotech (PBYI) received a significant boost, achieving a Zacks Rank #1, indicating a **Strong Buy** rating. This upgrade is a result of…
Italian VC XGEN Venture Leads the Charge XGEN Venture, an innovative European venture capital firm, has officially launched its inaugural fund with a substantial capital commitment of **€180 million** (approximately…
### Exciting Developments in Holly Springs A promising biotechnology firm in Holly Springs is set to unveil a significant expansion that could create hundreds of additional job opportunities in the…